Saudi Pharmaceutical Industries and Medical Appliances Reports First Quarter 2025 Earnings

Saudi Pharmaceutical Industries and Medical Appliances (TADAWUL:2070) First Quarter 2025 Results

Key Financial Results

• Revenue: ر.س485.0m (up 2.0% from 1Q 2024).
• Net income: ر.س75.0m (up 114% from 1Q 2024).
• Profit margin: 16% (up from 7.4% in 1Q 2024).

Our free stock report includes 2 warning signs investors should be aware of before investing in Saudi Pharmaceutical Industries and Medical Appliances. Read for free now.

All figures shown in the chart above are for the trailing 12 month (TTM) period

Saudi Pharmaceutical Industries and Medical Appliances Earnings Insights

Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years, compared to a 9.5% growth forecast for the Pharmaceuticals industry in Asia.

Performance of the market in Saudi Arabia.

The company's shares are up 4.7% from a week ago.

Risk Analysis

It is worth noting though that we have found 2 warning signs for Saudi Pharmaceutical Industries and Medical Appliances (1 is a bit concerning!) that you need to take into consideration.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.